Cytotoxicity of mononuclear cells as induced by peritoneal dialysis fluids: Insight into mechanisms that regulate osmotic stress-related apoptosis

Peritoneal Dialysis International

Volumn 28, Issue 6, 2008, Pages 655-666

  Gastaldello, Karine ^a   Husson, Cecile ^a   Dondeyne, Jean Paul ^a   Vanherweghem, Jean Louis ^b   Tielemans, Christian ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Apoptosis; Caspase 3; Cell volume regulation; Cytoskeleton; Cytotoxicity; Hyperosmolality; Hypertonicity; Peritoneal dialysis fluids

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CYTOCHALASIN D; F ACTIN; HYPERTONIC SOLUTION; LIPOCORTIN 5; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID; PHALLOIDIN; PROPIDIUM IODIDE; ACTIN; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CYSTEINE PROTEINASE INHIBITOR; DIALYSIS FLUID; NUCLEIC ACID SYNTHESIS INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL AGGREGATION; CELL DEATH; CELL LABELING; CELL MEMBRANE PERMEABILITY; CELL SHRINKAGE; CELL VOLUME; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HYPEROSMOLALITY; IONIC STRENGTH; OSMOTIC STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CHEMISTRY; FLOW CYTOMETRY; METABOLISM; OSMOTIC PRESSURE; OXIDATIVE STRESS; PHOSPHORYLATION; PHYSIOLOGY;

ACTINS; AMINO ACID CHLOROMETHYL KETONES; ANNEXIN A5; APOPTOSIS; CASPASE 3; CYSTEINE PROTEINASE INHIBITORS; CYTOCHALASIN D; CYTOSKELETON; DIALYSIS SOLUTIONS; FLOW CYTOMETRY; HUMANS; HYPERTONIC SOLUTIONS; NUCLEIC ACID SYNTHESIS INHIBITORS; OSMOTIC PRESSURE; OXIDATIVE STRESS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 60249098131     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800619     Document Type: Article

References (28)

1. Duwe AK, Vas SI, Weatherhead JW. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
2. Liberek T, Topley N, Jörres A, Coles GA, Gahl GM, Williams JD. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. J Am Soc Nephrol 1993; 3:1508-15.
3. Jorres A, Topley N, Witowski J, Liberek T, Gahl GM. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1993; 13(Suppl 2):S291-4.
4. Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Effect of hyperosmolality upon mesothelial monolayer exposed in vivo and in situ to a mannitol-enriched dialysis solution. Nephron 1999; 81:301-9.
5. de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Donker AJ, et al. Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo. Adv Perit Dial 1991; 7:150-3.
6. Mortier S, Lameire NH, De Vriese AS. The effects of peritoneal dialysis solutions on peritoneal host defense. Perit Dial Int 2004; 24:123-38.
7. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
8. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, et al.; EAPOS Group. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67:1609-15.
9. de Fijter CW, Verbrugh HA, Oe LP, Heezius E, Donker AJ, Verhoef J, et al. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21:411-18.
10. Brulez HF, Heezius EC, de Fijter CW, Oe LP, Verhoef J, Verbrugh HA. In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. Adv Perit Dial 1994; 10:241-4.
11. Mortier S, De Vriese AS, Lameire N. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions. Blood Purif 2003; 21:14-23.
12. Lang F. Cell Volume Regulation. Basel: Karger; 1998.
13. Lang F, Busch GL, Volkl H. The diversity of volume regulatory mechanisms. Cell Physiol Biochem 1998; 8(1-2):1-45.
14. Gomez-Angelats M, Bortner CD, Cidlowski JA. Cell volume regulation in immune cell apoptosis. Cell Tissue Res 2000; 301:33-42.
15. Pedersen SF, Hoffmann EK, Mills JW. The cytoskeleton and cell volume regulation. Comp Biochem Physiol A Mol Integr Physiol 2001; 130:385-99.
16. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2665-72.
17. Gotloib L, Wajsbrot V, Shostak A. Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine. Free Radic Biol Med 2003; 34:419-28.
18. -. Am J Physiol Renal Physiol 2004; 286:F1046-F1053.
19. Gastaldello K, Husson C, Tielemans C, Vanherweghem JL. Glucose degradation products (GDP) in peritoneal dialysis fluids (PDF) modulate leukocytes functions and viability [Abstract]. J Am Soc Nephrol 2000; 11:A1105.
20. Bonventre JV. Molecular response to cytotoxic injury: role of inflammation, MAP kinases, and endoplasmic reticulum stress response. Semin Nephrol 2003; 23:439-48.
21. Németh ZH, Deitch EA, Davidson MT, Szabo C, Vizi ES, Hasko G. Disruption of the actin cytoskeleton results in nuclear factor-kappaB activation and inflammatory mediator production in cultured human intestinal epithelial cells. J Cell Physiol 2004; 200:71-81.
22. Kim SJ, Hwang SG, Kim IC, Chun JS. Actin cytoskeletal architecture regulates nitric oxide-induced apoptosis, dedifferentiation, and cyclooxygenase-2 expression in articular chondrocytes via mitogen activated protein kinase and protein kinase C pathways. J Biol Chem 2003; 278: 42448-56.
23. Schäfer C, Clapp P, Welsh J, Benndorf R, Williams JA. HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells. Am J Physiol 1999; 277: C1032-C1043.
24. Bijian K, Takano T, Papillon J, Le Berre L, Michaud JL, Kennedy CR, et al. Actin cytoskeleton regulates extracellular matrix-dependent survival signals in glomerular epithelial cells. Am J Physiol Renal Physiol 2005; 289: F1313-F1323.
25. Genesca M, Sola A, Hotter G. Actin cytoskeleton derangement induces apoptosis in renal ischemia/reperfusion. Apoptosis 2006; 11:563-71.
26. Korichneva I, Hämmerling U. F-actin as a functional target for retro-retinoids: a potential role in anhydroretinol-triggered cell death. J Cell Science 1999; 112:2521-8.
27. White SR, Williams P, Wojcik KR, Sun S, Hiemstra PS, Rabe KF, et al. Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 2001; 24:282-94.
28. Breborowicz A, Polubinska A, Oreopoulos DG. Changes in volume of peritoneal mesothelial cells exposed to osmotic stress. Perit Dial Int 1999; 19:119-23.